Corporate News – Market Performance Update
Novonesis B (ticker: NSIS‑B.CO) closed up 1.54 % during the 24‑hour period ending at 01:28 AM Central Europe on Wednesday, 21 March 2026. A single share of Novonesis B is trading at approximately DKK 463 on major exchanges.
- Outstanding shares: 466 million
- Market capitalization: DKK 214.8 billion
- Trading volume (last 24 h): DKK 240.2 million
- Monthly change: +7.27 % since the end of February 2026
- 200‑day simple moving average: DKK 402.52
- 52‑week high: DKK 465 (recorded 01 September 2026)
- 52‑week low: DKK 336.8 (recorded 19 March 2026)
Recent Performance of Related Stocks (Last 24 h)
| Stock | Ticker | Daily change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Ørsted A | ORSTED.CO | –2.88 % | DKK 124.95 | DKK 165.6 bn | – |
| Pandora A | PNDORA.CO | –0.12 % | DKK 841.6 | DKK 60 bn | 12.44 |
| Carlsberg A | CARL‑A.CO | –1.38 % | DKK 1,060 | DKK 143.4 bn | 19.61 |
| Coloplast B | COLO‑B.CO | –1.12 % | DKK 476 | DKK 105.4 bn | 38.13 |
| Ascendis Pharma A | A710.F | 0 % | EUR 204 | EUR 13.3 bn | 18.12 |
Company Profile – Novonesis B
Novonesis B is a subsidiary of Novozymes A/S, a Danish company headquartered in Bagsvær. Novozymes specializes in the production and sale of industrial enzymes and microorganisms worldwide. The company’s performance is influenced by its position in the biopharmaceutical and industrial enzyme markets, as well as by global supply chain dynamics.
No additional editorial commentary or author attribution is provided.
